Kerr Corporation: FDA filings under this applicant name
FDA lists 41 510(k) clearances under 2 spellings of the applicant name “Kerr Corporation” (first 2000, latest 2026), across 11 product codes in 1 review panel. Median 510(k) review time under this name: 86 days. Since 2017 the median was 121 days, against 119 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Envista (Nobel Biocare, Ormco, Kerr), based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 2 | 110 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 3 | 112 |
| 2017 | 4 | 210 |
| 2018 | 1 | 89 |
| 2019 | 1 | 121 |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 1 | 121 |
| 2023 | 1 | 115 |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 1 | 118 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Kerr Corporation took a median 121 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 119 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| EBF | Material, Tooth Shade, Resin | 9 | 9 |
| ELW | Material, Impression | 8 | 8 |
| EBZ | Activator, Ultraviolet, For Polymerization | 6 | 6 |
| MVL | Cord, Retraction | 5 | 5 |
| KLE | Agent, Tooth Bonding, Resin | 4 | 4 |
| EMA | Cement, Dental | 3 | 3 |
| KIF | Resin, Root Canal Filling | 2 | 2 |
| EBG | Crown And Bridge, Temporary, Resin | 1 | 1 |
| MZW | Dental Cement W/Out Zinc-Oxide Eugenol As An Ulcer Covering For Pain Relief | 1 | 1 |
| NTK | Light Transmission Caries Detector | 1 | 1 |
Plus 1 more product codes.
Review panels
- Dental (41)
Most recent Kerr Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K252890 | ZenSeal Pro | KIF | 2026-01-07 | 118 |
| K222830 | Rainbow 360 | KLE | 2023-01-12 | 115 |
| K221255 | SimpliShade Bulk Fill, SimpliShade Bulk Fill Flow | EBF | 2022-08-31 | 121 |
| K191548 | Nexus Universal Self-Cure | EMA | 2019-10-11 | 121 |
| K182162 | OptiBond eXTRa Universal | KLE | 2018-11-07 | 89 |
| K162948 | Styptin, Hemogin-L, Hemodettes, and GingiGEL Aluminum Chloride Impregnated Retraction Cord/Materials | MVL | 2017-08-08 | 291 |
| K163064 | Demi Ultra | EBZ | 2017-07-18 | 258 |
| K162536 | GingiKnit+, GingiBraid+, GingiBraid+ Shortcut, and UniBraid+ impregnated Aluminum Potassium Sulfate Retraction Cord | MVL | 2017-02-03 | 144 |
| K162164 | GingiKnit+, GingiBraid+, and Shortcut with GingiBraid+ Non-Impregnated Retraction Cord | MVL | 2017-01-13 | 163 |
| K162436 | EndoVac Pure | NYL | 2016-12-21 | 112 |
31 earlier clearances. See the full list in Caduvo.
Recalls
64 product recalls in 16 recall events; 0 initiated in the last five years. Most recent: 2014-05-29.
3 product recalls in 3 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical (2), Henry Schein, Inc. (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Kerr Corporation is the lead sponsor of 1 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT06002880: Clinical Evaluation of OBU When Used for Indirect Dental Restorations (Terminated, started 2023-07-14)
Parent company SEC filings
Envista Holdings Corp (NVST): EDGAR filings, CIK 1757073. Caduvo groups Kerr Corporation under Envista (Nobel Biocare, Ormco, Kerr); the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Kerr Corporation (32)
- Kerr Corp. (9)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Kerr Corporation (Danbury) (32 510(k)s)
- Kerr Dental Materials Center (17 510(k)s)
- Kerr Hearing Aid Laboratory (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Kerr Corporation?
FDA lists 41 510(k) clearances under 2 spellings of the applicant name “Kerr Corporation” (first 2000, latest 2026), across 11 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Kerr Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Kerr Corporation is 86 days. Since 2017: 121 days, versus 119 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Kerr Corporation?
The most frequent FDA product codes under this applicant name are EBF (Material, Tooth Shade, Resin, 9); ELW (Material, Impression, 8); EBZ (Activator, Ultraviolet, For Polymerization, 6).
Next steps
- See all 41 Kerr Corporation clearances with predicates and recalls
- Run predicate analysis for product code EBF, Kerr Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.